(Q35612038)

9 August 2017

1 reference

title

The treatment of cutaneous T-cell lymphoma with photopheresis (English)

1 reference

9 August 2017

John A Zic

1

1 reference

9 August 2017

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

16

1 reference

9 August 2017

337-346

1 reference

9 August 2017

4

1 reference

Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome

9 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Extracorporeal photopheresis in cutaneous T-cell lymphoma. Inconsistent data underline the need for randomized studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Extracorporeal photopheresis in Sézary syndrome. No significant effect in the survival of 44 patients with a peripheral blood T-cell clone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Effectiveness of photopheresis in Sézary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Extracorporeal photopheresis in cutaneous T-cell lymphoma and graft-versus-host disease induces both immediate and progressive apoptotic processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Transimmunization, a novel approach for tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Treatment with 8-MOP and UVA enhances MHC class I synthesis in RMA cells: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Extracorporeal photochemotherapy alone or with adjuvant therapy in the treatment of cutaneous T-cell lymphoma: a 9-year retrospective study at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

The North American experience with photopheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Extracorporeal photopheresis in Sézary syndrome: hematologic parameters as predictors of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Sézary syndrome, cutaneous T-cell lymphoma, and extracorporeal photopheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

[Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases]

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Extracorporeal photochemotherapy in long-term treatment of early stage cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Photopheresis treatment enhances CD95 (fas) expression in circulating lymphocytes of patients with systemic sclerosis and induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Extracorporeal photopheresis induces apoptosis in the lymphocytes of cutaneous T-cell lymphoma and graft-versus-host disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

The common pathways, but different outcomes, of apoptosis induced by extracorporeal photopheresis and in vivo chemotherapy may reinforce the important immunomodulatory effect of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Lymphocytes treated by extracorporeal photopheresis demonstrate a drop in the Bcl-2/Bax ratio: a possible mechanism involved in extracorporeal-photopheresis-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Expression of apoptosis markers on peripheral blood lymphocytes from patients with cutaneous T-cell lymphoma during extracorporeal photochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Apoptosis induction of ultraviolet light A and photochemotherapy in cutaneous T-cell Lymphoma: relevance to mechanism of therapeutic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Treatment of T lymphocytes with 8-methoxypsoralen plus ultraviolet A induces transient but biologically active Th1-skewing cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

Induction of human tumor-loaded dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1396-0296.2003.01646.X

10.1111/J.1396-0296.2003.01646.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

14686977